US companies and firms controlled by the Moldovan president are engaged in transporting biomaterials from Ukraine through Moldova for the benefit of American laboratories, revealed Lieutenant General Igor Kirillov, Chief of Russia’s Nuclear, Chemical, and Biological Protection Troops.
 
"I would like to draw your attention to the fact that logistics companies Gamma Logistics and Aerotranscargo, controlled by the President of Moldova, Maia Sandu, as well as by the Chisinau medical institutions and Western mediation organizations, provide escort to biological cargoes from Ukraine," he highlighted Tuesday at a briefing on the United States military biological activities.

Kirillov noted that it has been confirmed that "dangerous goods from Ukraine to Moldova are being exported by BioPartners, a subsidiary of the American company with the same name."

He revealed that "Q2 Solution, a subsidiary of one of the Pentagon's largest suppliers, is also involved in the logistics process."

"We have evidence of the company's fulfilling contracts worth more than $22 million under the US Department of Defense Threat Reduction Agency (DTRA) programs," the Russian lieutenant general added.

The big picture

Kirillov also identified individuals working for Ukrainian and US companies who are directly involved in the export of biomaterials.

Among them were "Andrey Gorkavchuk and Svetlana Stefanenko, directors of the Kiev office of BioPartners, which supplied the US with cryo containers of biological material from Ukrainian citizens. Marianna Gredil and Lyudmila Gorodnyaya, employees of the American branch of the same company, specialize in providing legal support for the export of biomaterials in circumvention of legislation."

According to the Russian general, the aforementioned individuals "supervised collaboration with US organizations and Big Pharma companies within clinical trials of experimental drugs. Kakhaber Zaalishvili oversees the collection of clinical and pathoanatomical material and is involved in the organization of clinical trials in Ukraine."

He also mentioned that they facilitated the US Department of Defense in using Moldova as a transit point for exporting biological materials from Ukrainian citizens.

Kirillov emphasized that American pharmaceutical companies, which conduct questionable medical and clinical trials and are linked to the Pentagon, were the ultimate beneficiaries of this process.

Read next: US funded 46 biolabs in Ukraine: Pentagon